Evidence map›Paper›PMID 42223598›Full record

ArticleDysphagia2026

The Guided Oral-Intake and Swallowing Test (GOST): Validation of a Novel Bedside Composite Score for Dysphagia Against Instrumental Assessment.

Yohei Teramoto, Kenji Suzuki, Shin Matsumoto, Satoshi Fukuzawa, Tetsuro Wada, Yukiyo Shimizu, Yasushi Hada

Abstract read
PubMed Publisher
In one paragraph

Article in Dysphagia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yohei TeramotoRehabilitation Department, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan. teramoto.yohei.kf@ms.hosp.tsukuba.ac.jp.ORCID http://orcid.org/0009-0004-7311-8066
Kenji SuzukiPLIMES Inc, Tsukuba, Ibaraki, Japan.
Shin MatsumotoDepartment of Otolaryngology, Head and Neck Surgery, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Satoshi FukuzawaOral and Maxillofacial Surgery, Department of Clinical Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Tetsuro WadaDepartment of Otolaryngology, Head and Neck Surgery, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Yukiyo ShimizuDepartment of Rehabilitation Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Yasushi HadaDepartment of Rehabilitation Medicine, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Funding

Japan Agency for Medical Research and Development 24015371
6 · The paper itself

Abstract

Videofluoroscopy (VF) and videoendoscopy (VE) remain the gold standards for evaluating dysphagia severity. The Dysphagia Outcome and Severity Scale (DOSS), based on these tests, is widely used as a reference. However, such assessments are not always feasible in clinical practice, highlighting the need for a practical alternative. In response, we have developed the Guided Oral-intake and Swallowing Test (GOST).To validate the Gauge of DOSS (GDOSS), a key indicator derived from GOST, by comparing it with instrumental assessments (VF/VE) using DOSS as the reference.We retrospectively analyzed 67 inpatients who underwent both GDOSS assessment and DOSS scoring via VF or VE. The median DOSS level from three independent raters was used as the reference. Correlation (Spearman's ρ), agreement (MAE, RMSE), and categorical concordance (weighted kappa) between GDOSS and DOSS were examined. Predictive validity was evaluated using ordinal logistic regression. GDOSS demonstrated a strong correlation with DOSS (ρ=0.716, p<0.001).Furthermore, it showed good agreement across various metrics (MAE= 0.881; RMSE= 1.203; weighted κ=0.749). GDOSS also emerged as a robust independentpredictor of DOSS levels (OR = 3.79, p<0.001), even after adjusting for potential confounders.Rather than replicating exact DOSS levels, GDOSS effectively estimates a clinically meaningful severity range, reflecting both functional capacity and safety. Its integrative and probabilistic nature supports GDOSS as a valid and practical tool, especially where instrumental assessments are limited. Future studies should explore its longitudinal responsiveness and role in clinical decision-making.

Indexed as

AssessmentDeglutitionDOSSDysphagiaFEESGDOSSGOSTVFSS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.